What are the major opportunities in the GLP-1 receptor agonist market? What are the strategies for the GLP-1 receptor agonist market?

For detailed insights on the major opportunities and strategies in the GLP-1 receptor agonist market, Read More

How does the GLP-1 receptor agonist market relate to the overall economy and other similar markets?

For detailed insights on GLP-1 receptor agonist market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the GLP-1 receptor agonist market growth? SWOT analysis of the GLP-1 receptor agonist market.

For detailed insights on the key dynamics influencing the GLP-1 receptor agonist market growth and SWOT analysis of the GLP-1 receptor agonist industry, Read More

GLP-1 Receptor Agonist Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

GLP-1 Receptor Agonist Market Report 2026

Name: GLP-1 Receptor Agonist Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs ), By Route Of Administration (Parenteral, Oral ), By End Users (Hospitals, Surgical Clinics, Other Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

GLP-1 Receptor Agonist Market Overview

• GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025

• Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%

• Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market

• Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under GLP-1 Receptor Agonist Market?

A GLP-1 receptor agonist is a type of medication that stimulates insulin release at high blood glucose levels and suppresses glucagon secretion under low blood glucose conditions. They are used to treat type 2 diabetes mellitus.

The main drug class of GLP-1 receptor agonist is liraglutide, dulaglutide, lixisenatide, and others. Liraglutide is a GLP-1 receptor agonist that acts by helping the pancreas to release the right amount of insulin when blood sugar levels are high. The route of administration involved is parenteral, and oral which are used by hospitals, surgical clinics, and others.

GLP-1 Receptor Agonist Market Global Report 2026 Market Report bar graph

What Is The GLP-1 Receptor Agonist Market Size and Share 2026?

The glp-1 receptor agonist market size has grown strongly in recent years. It will grow from $14.09 billion in 2025 to $14.83 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of type 2 diabetes, increased awareness of glycemic control therapies, strong clinical efficacy versus traditional antidiabetics, physician preference for incretin-based therapies, favorable reimbursement in developed markets.

What Is The GLP-1 Receptor Agonist Market Growth Forecast?

The glp-1 receptor agonist market size is expected to see strong growth in the next few years. It will grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing obesity population, expanding approval for cardiovascular risk reduction, innovation in oral and combination therapies, increased penetration in emerging markets, rising patient preference for weight loss benefits. Major trends in the forecast period include expansion of glp-1 therapies beyond diabetes, rising demand for long-acting and once-weekly formulations, growth of oral glp-1 receptor agonists, increasing focus on weight management indications, strategic partnerships and licensing agreements.

Book your 30 minutes free consultation with our research experts

Global GLP-1 Receptor Agonist Market Segmentation

1) By Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs

2) By Route Of Administration: Parenteral, Oral

3) By End Users: Hospitals, Surgical Clinics, Other Users

What Is The Driver Of The GLP-1 Receptor Agonist Market?

The rising prevalence of diabetes is expected to propel the GLP-1 receptor agonist market going forward. Diabetes is a chronic illness that develops when the pancreas either produces insufficient amounts of insulin or when the body cannot properly utilize the insulin that it does. High blood sugar is a symptom of the metabolic disorder diabetes mellitus. GLP-1 receptor agonist is used in diabetes to stimulate the body to produce more insulin, which helps to lower blood sugar levels, so the rising prevalence of diabetes will propel the market growth. For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%. Therefore, the rising prevalence of diabetes is driving the GLP-1 receptor agonist industry.

Key Players In The Global GLP-1 Receptor Agonist Market

Major companies operating in the glp-1 receptor agonist market are Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiangsu Hengrui Medicine Co., Sun Pharmaceuticals Industries Ltd., PegBio Co. Ltd., Zealand Pharma A/S, Bristol-Myers Squibb Company, Chongqing Lummy Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Dong-A ST Co. Ltd., Eisai Co. Ltd., HanAll Biopharma Co. Ltd., Ipsen SA, Johnson & Johnson, Merck & Co. Inc., Novartis AG.

Global GLP-1 Receptor Agonist Market Trends and Insights

Major companies operating in the GLP-1 receptor agonist market are focused on developing sustained-release GLP-1 receptor agonists to gain a competitive edge in the market. Sustained-release GLP-1 receptor agonists (GLP-1RAs) are a type of medication that slowly releases GLP-1RA into the bloodstream over time, which allows for longer-lasting effects and less frequent injections compared to traditional GLP-1RAs. For instance, in April 2023, Mitsubishi Tanabe Pharma Corporation, a Japan-based pharmaceuticals company, launched Mounjaro 2.5 mg or 5 mg Ateos. It is the world's first sustained-release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes that activates both the GLP-1 and GIP receptors. The GLP-1 receptor is involved in regulating blood sugar levels, while the GIP receptor is involved in stimulating insulin secretion and reducing appetite.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The GLP-1 Receptor Agonist Market?

In July 2024, Roche, a Swiss-based pharmaceuticals company, acquired Carmot Therapeutics for US$ 2.7 billion (with up to US$ 400 million in additional milestone payments). With this acquisition, Roche aimed to strengthen its metabolic disease franchise by gaining access to Carmot’s advanced portfolio, particularly a phase-2-ready dual GLP-1/GIP receptor agonist, thereby enhancing its competitive position in both obesity and diabetes markets. Carmot Therapeutics is a U.S.-based biotech company focused on developing incretin-based therapies, including CT-388 (a weekly injectable dual GLP-1/GIP agonist), an oral small-molecule GLP-1 agonist (CT-996), and another injectable GLP-1/GIP candidate (CT-868).

Regional Insights

North America was the largest region in the GLP-1 receptor agonist market in 2025. Asia-Pacific is expected to be the fastest-growing region in the GLP-1 receptor agonist market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the GLP-1 Receptor Agonist Market?

The GLP-1 receptor agonist market consists of sales of dulaglutide, bydureon b-cise, exenatide, and semaglutide. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the GLP-1 Receptor Agonist Market Report 2026?

The glp-1 receptor agonist market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the glp-1 receptor agonist industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

GLP-1 Receptor Agonist Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$14.83 billion
Revenue Forecast In 2035	$18.32 billion
Growth Rate	CAGR of 5.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Route Of Administration, End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiangsu Hengrui Medicine Co., Sun Pharmaceuticals Industries Ltd., PegB
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. GLP-1 Receptor Agonist Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global GLP-1 Receptor Agonist Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. GLP-1 Receptor Agonist Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global GLP-1 Receptor Agonist Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Glp-1 Therapies Beyond Diabetes

4.2.2 Rising Demand For Long-Acting And Once-Weekly Formulations

4.2.3 Growth Of Oral Glp-1 Receptor Agonists

4.2.4 Increasing Focus On Weight Management Indications

4.2.5 Strategic Partnerships And Licensing Agreements

5. GLP-1 Receptor Agonist Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diabetes Specialty Clinics

5.3 Endocrinology Clinics

5.4 Ambulatory Care Centers

5.5 Home Healthcare Providers

6. GLP-1 Receptor Agonist Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global GLP-1 Receptor Agonist Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global GLP-1 Receptor Agonist PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global GLP-1 Receptor Agonist Market Size, Comparisons And Growth Rate Analysis

7.3. Global GLP-1 Receptor Agonist Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global GLP-1 Receptor Agonist Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global GLP-1 Receptor Agonist Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. GLP-1 Receptor Agonist Market Segmentation

9.1. Global GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs

9.2. Global GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parenteral, Oral

9.3. Global GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Surgical Clinics, Other Users

10. GLP-1 Receptor Agonist Market Regional And Country Analysis

10.1. Global GLP-1 Receptor Agonist Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global GLP-1 Receptor Agonist Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific GLP-1 Receptor Agonist Market

11.1. Asia-Pacific GLP-1 Receptor Agonist Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China GLP-1 Receptor Agonist Market

12.1. China GLP-1 Receptor Agonist Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India GLP-1 Receptor Agonist Market

13.1. India GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan GLP-1 Receptor Agonist Market

14.1. Japan GLP-1 Receptor Agonist Market Overview

14.2. Japan GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia GLP-1 Receptor Agonist Market

15.1. Australia GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia GLP-1 Receptor Agonist Market

16.1. Indonesia GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea GLP-1 Receptor Agonist Market

17.1. South Korea GLP-1 Receptor Agonist Market Overview

17.2. South Korea GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan GLP-1 Receptor Agonist Market

18.1. Taiwan GLP-1 Receptor Agonist Market Overview

18.2. Taiwan GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia GLP-1 Receptor Agonist Market

19.1. South East Asia GLP-1 Receptor Agonist Market Overview

19.2. South East Asia GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe GLP-1 Receptor Agonist Market

20.1. Western Europe GLP-1 Receptor Agonist Market Overview

20.2. Western Europe GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK GLP-1 Receptor Agonist Market

21.1. UK GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany GLP-1 Receptor Agonist Market

22.1. Germany GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France GLP-1 Receptor Agonist Market

23.1. France GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy GLP-1 Receptor Agonist Market

24.1. Italy GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain GLP-1 Receptor Agonist Market

25.1. Spain GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe GLP-1 Receptor Agonist Market

26.1. Eastern Europe GLP-1 Receptor Agonist Market Overview

26.2. Eastern Europe GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia GLP-1 Receptor Agonist Market

27.1. Russia GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America GLP-1 Receptor Agonist Market

28.1. North America GLP-1 Receptor Agonist Market Overview

28.2. North America GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA GLP-1 Receptor Agonist Market

29.1. USA GLP-1 Receptor Agonist Market Overview

29.2. USA GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada GLP-1 Receptor Agonist Market

30.1. Canada GLP-1 Receptor Agonist Market Overview

30.2. Canada GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America GLP-1 Receptor Agonist Market

31.1. South America GLP-1 Receptor Agonist Market Overview

31.2. South America GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil GLP-1 Receptor Agonist Market

32.1. Brazil GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East GLP-1 Receptor Agonist Market

33.1. Middle East GLP-1 Receptor Agonist Market Overview

33.2. Middle East GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa GLP-1 Receptor Agonist Market

34.1. Africa GLP-1 Receptor Agonist Market Overview

34.2. Africa GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. GLP-1 Receptor Agonist Market Regulatory and Investment Landscape

36. GLP-1 Receptor Agonist Market Competitive Landscape And Company Profiles

36.1. GLP-1 Receptor Agonist Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. GLP-1 Receptor Agonist Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. GLP-1 Receptor Agonist Market Company Profiles

36.3.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

37. GLP-1 Receptor Agonist Market Other Major And Innovative Companies

Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiangsu Hengrui Medicine Co., Sun Pharmaceuticals Industries Ltd., PegBio Co. Ltd., Zealand Pharma A/S, Bristol-Myers Squibb Company, Chongqing Lummy Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Dong-A ST Co. Ltd., Eisai Co. Ltd., HanAll Biopharma Co. Ltd., Ipsen SA

38. Global GLP-1 Receptor Agonist Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The GLP-1 Receptor Agonist Market

40. GLP-1 Receptor Agonist Market High Potential Countries, Segments and Strategies

40.1 GLP-1 Receptor Agonist Market In 2030 - Countries Offering Most New Opportunities

40.2 GLP-1 Receptor Agonist Market In 2030 - Segments Offering Most New Opportunities

40.3 GLP-1 Receptor Agonist Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global GLP-1 Receptor Agonist Market, Overview Of Key Products - Product Examples

Table 2: Global GLP-1 Receptor Agonist Market Attractiveness, Factor-Wise Evaluation

Table 3: Global GLP-1 Receptor Agonist Market, Supply Chain Analysis

Table 4: Global GLP-1 Receptor Agonist Market, Major Raw Material Providers

Table 5: Global GLP-1 Receptor Agonist Market, Major Resource Providers

Table 6: Global GLP-1 Receptor Agonist Market, Major Manufacturers (Suppliers)

Table 7: Global GLP-1 Receptor Agonist Market, Major Distributors And Channel Partners

Table 8: Global GLP-1 Receptor Agonist Market, Key Technologies & Future Trends

Table 9: Global GLP-1 Receptor Agonist Market, Major Trends

Table 10: Global GLP-1 Receptor Agonist Market, Major End Users

Table 11: Global GLP-1 Receptor Agonist Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global GLP-1 Receptor Agonist Historic Market Growth, 2020-2025, $ Billion

Table 13: Global GLP-1 Receptor Agonist Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global GLP-1 Receptor Agonist Market - TAM, US$ Billion, 2025

Table 15: Global GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global GLP-1 Receptor Agonist Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global GLP-1 Receptor Agonist Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Indonesia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Indonesia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: South Korea, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: South Korea, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Taiwan, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Taiwan, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South East Asia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South East Asia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Western Europe, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Western Europe, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: UK, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: UK, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Germany, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Germany, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: France, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: France, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Italy, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Italy, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Spain, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Spain, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Eastern Europe, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Eastern Europe, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Russia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Russia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: North America, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: North America, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: USA, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: USA, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Canada, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Canada, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: South America, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: South America, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Brazil, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Brazil, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Middle East, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Middle East, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Africa, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Africa, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Global GLP-1 Receptor Agonist Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 93: Global GLP-1 Receptor Agonist Market - Company Scoring Matrix

Table 94: Novo Nordisk A/S Financial Performance

Table 95: Sanofi SA Financial Performance

Table 96: Eli Lilly and Company Financial Performance

Table 97: AstraZeneca Inc. Financial Performance

Table 98: Boehringer Ingelheim International GmbH Financial Performance

Table 99: Global GLP-1 Receptor Agonist Market, Competitive Benchmarking (In USD Billions)

Table 100: Global GLP-1 Receptor Agonist Market, Competitive Dashboard

Table 101: Global GLP-1 Receptor Agonist Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 102: Global, GLP-1 Receptor Agonist Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 103: Global, GLP-1 Receptor Agonist Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 104: Global, GLP-1 Receptor Agonist Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

Figure 1: Global GLP-1 Receptor Agonist Market, Overview Of Key Products - Product Examples

Figure 2: Global GLP-1 Receptor Agonist Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global GLP-1 Receptor Agonist Market, Supply Chain Analysis

Figure 4: Global GLP-1 Receptor Agonist Market, Major Raw Material Providers

Figure 5: Global GLP-1 Receptor Agonist Market, Major Resource Providers

Figure 6: Global GLP-1 Receptor Agonist Market, Major Manufacturers (Suppliers)

Figure 7: Global GLP-1 Receptor Agonist Market, Major Distributors And Channel Partners

Figure 8: Global GLP-1 Receptor Agonist Market, Key Technologies & Future Trends

Figure 9: Global GLP-1 Receptor Agonist Market, Major Trends

Figure 10: Global GLP-1 Receptor Agonist Market, Major End Users

Figure 11: Global GLP-1 Receptor Agonist Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global GLP-1 Receptor Agonist Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global GLP-1 Receptor Agonist Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global GLP-1 Receptor Agonist Market - TAM, US$ Billion, 2025

Figure 15: Global GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global GLP-1 Receptor Agonist Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global GLP-1 Receptor Agonist Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Indonesia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Indonesia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: South Korea, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: South Korea, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Taiwan, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Taiwan, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South East Asia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South East Asia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Western Europe, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Western Europe, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: UK, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: UK, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Germany, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Germany, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: France, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: France, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Italy, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Italy, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Spain, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Spain, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Eastern Europe, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Eastern Europe, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Russia, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Russia, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: North America, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: North America, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: USA, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: USA, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Canada, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Canada, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: South America, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: South America, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Brazil, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Brazil, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Middle East, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Middle East, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Africa, GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Africa, GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Global GLP-1 Receptor Agonist Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 93: Global GLP-1 Receptor Agonist Market - Company Scoring Matrix

Figure 94: Novo Nordisk A/S Financial Performance

Figure 95: Sanofi SA Financial Performance

Figure 96: Eli Lilly and Company Financial Performance

Figure 97: AstraZeneca Inc. Financial Performance

Figure 98: Boehringer Ingelheim International GmbH Financial Performance

Figure 99: Global GLP-1 Receptor Agonist Market, Competitive Benchmarking (In USD Billions)

Figure 100: Global GLP-1 Receptor Agonist Market, Competitive Dashboard

Figure 101: Global GLP-1 Receptor Agonist Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 102: Global, GLP-1 Receptor Agonist Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 103: Global, GLP-1 Receptor Agonist Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 104: Global, GLP-1 Receptor Agonist Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Latest Market Developments in Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Industry: Forecast 2025–2029

Industry Trends Show Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Set to Expand at 10.7% CAGR Until 2029

Strategic Report on Pharmaceutical Impurity Synthesis and Isolation Services Market: Growth Opportunities and Emerging Challenges

2025 Pregnancy Care Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Veterinary CRO And CDMO Market Report 2026 - Global Outlook – By Service Type (Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing), By Animal Type (Companion Animals, Livest...

Evaporated Goat Milk Market Report 2026 - Global Outlook – By Type (Skimmed Evaporated Milk, Whole Evaporated Milk), By Application (Dairy Products, Bakeries, Confectionery, Other Applications), By Distribution Channel (...

Weapon Mounts Market Report 2026 - Global Outlook – By Platform (Ground, Naval, Airborne), By Operation (Manned, Remotely Operated), By Application (National Defense, Security, Business Performance, Other Applications) –...

Tree Services Market Report 2026 - Global Outlook – By Type (Tree Care, Tree Landscaping), By Tree Type (Deciduous Trees, Coniferous Trees, Fruit Trees, Ornamental Trees), By Application (Residential, Municipal, Commerci...

Weapon Mounts Market Report 2026 - Global Outlook – By Platform (Ground, Naval, Airborne), By Operation (Manned, Remotely Operated), By Application (National Defense, Security, Business Performance, Other Applications) –...

Virtual Reality (VR) In Medical Simulation Market Report 2026 - Global Outlook – By Age Group (Adult, Children, Infant), By Application (Medical Education, Virtual Reality In Diagnostics, Pain Management, Mental Illness ...

Frequently Asked Questions

How big is the GLP-1 Receptor Agonist Market?

The GLP-1 Receptor Agonist market was valued at $14.09 billion in 2025, increased to $14.83 billion in 2026, and is projected to reach $18.32 billion by 2030.

What is the GLP-1 Receptor Agonist market growth?

The global GLP-1 Receptor Agonist market is expected to grow at a CAGR of 5.4% from 2026 to 2035 to reach $18.32 billion by 2035.

Who are the key players in GLP-1 Receptor Agonist market?

Some Key Players in the GLP-1 Receptor Agonist market Include, Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiang

Major trend in this market includes: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity. For further insights on this market. request a sample here

North America was the largest region in the GLP-1 receptor agonist market in 2025. Asia-Pacific is expected to be the fastest-growing region in the GLP-1 receptor agonist market report during the forecast period. The regions covered in the g

Book your 30 minutes free consultation with our research experts

Contact Us